Company Filing History:
Years Active: 2012
Title: The Innovative Journey of Anne McGettrick: A Pioneering Inventor in TRAM Modulation
Introduction: Anne McGettrick, hailing from Dublin, Ireland, is a prominent inventor with a focus on biotechnological innovations. With one patent to her name, she has made significant contributions to the understanding of the phosphorylation of TRAM (Trif-related adaptor molecule). Her work holds promise for advancements in therapeutic applications.
Latest Patents: Anne's patent, titled "Assays for determining compounds which modulate TRAM phosphorylation," delves into innovative assays that ascertain the phosphorylation state of TRAM. This biomolecule is critically phosphorylated upon stimulation by lipopolysaccharides through protein kinase C epsilon. The patent elucidates how detecting this phosphorylation state can lead to the identification of compounds that influence TRAM's functionality and its role in Toll Like Receptor 4 signaling pathways.
Career Highlights: Throughout her career, Anne has demonstrated a commitment to research and development in the pharmaceutical sector. Working at Opsona Therapeutics Limited, she has collaborated with talented professionals to enhance therapeutic strategies aimed at modulating immune responses. Her dedication to scientific excellence has positioned her as a valued contributor in her field.
Collaborations: Among her notable collaborations is her work alongside Luke O'Neill, a well-respected figure in immunology. Their combined expertise has led to a deeper understanding of the molecular mechanisms involved in immune modulation, elevating the research conducted at Opsona Therapeutics.
Conclusion: Anne McGettrick's work exemplifies the spirit of innovation and the impact of scientific inquiry in biotechnology. With her patent on TRAM phosphorylation assays, she paves the way for potential breakthroughs in therapeutic interventions. As she continues her journey at Opsona Therapeutics Limited, the scientific community eagerly anticipates the future contributions she will make to the field.